Clinical Trials Browser

Phase 1 × TAS-116 × Clear all

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms, Sarcoma, Alveolar Soft Part

NCT05655598 2024-09-19

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer

Phase 1 Withdrawn

GenitourinaryGynecologicSarcoma

Urinary Bladder Neoplasms, Sarcoma, Endometrial Neoplasms

NCT02965885 2024-09-04

A Study of TAS-116 in Patients With Solid Tumors

Phase 1 Completed

31 enrolled

Tumor-Agnostic

Neoplasms

Clinical Trials

AB122 Platform Study

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer

A Study of TAS-116 in Patients With Solid Tumors